510(k) K023592

SERAQUEST ANTI-THYROGLOBULIN by Quest Intl., Inc. — Product Code DDC

K023592 is an FDA 510(k) premarket notification submitted by Quest Intl., Inc. for the device "SERAQUEST ANTI-THYROGLOBULIN". The FDA issued a decision of Substantially Equivalent on Jan 6, 2003. The device falls under product code DDC (Thyroglobulin, Antigen, Antiserum, Control), a Class II device regulated under 21 CFR 866.5870. Quest Intl., Inc. has 24 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Jan 6, 2003
Date Received
Oct 25, 2002
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Thyroglobulin, Antigen, Antiserum, Control
Device Class
Class II
Regulation Number
866.5870
Review Panel
IM
Submission Type
510(k)

Need the full FDA record for Quest Intl., Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K023592. Report a data issue: hello@regdatalab.com.